Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus brevis SBC8803 and Improved Atopic Dermatitis Symptoms

Research synthesisLow evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects of Lactobacillus brevis SBC8803 on atopic dermatitis symptoms, though effect sizes ranged from small to moderate. The evidence is entirely from narrative reviews summarizing existing literature; no extractable data on dose, form, duration, or statistical significance were available. This evidence base is small and preliminary.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All studies are narrative reviews rather than controlled trials, so causal inference is limited. None of the studies reported statistical significance, effect doses, or study durations. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated May 12, 2026
3 of 3 papers
Back to top